Key message
This review addresses available literature on the presence of SARS-CoV-2 on tissues, gametes and embryos, with special reference to possible sources of cross-contamination through liquid nitrogen. Strategies for risk-mitigation are extrapolated from reports on other viruses to the current global crisis for safety in fertility treatment services, specifically oncofertility.